SEC Form 4/A · accession 0000899243-16-011349
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Eleanor Ramos
Officer — Chief Medical Officer
Period of report
Aug 17, 2015
Accepted (ET)
Jan 7, 2016 · 9:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | P | 10,000 | $20.00 | A | 10,000 | D | |
| Common Stock | Dec 22, 2015 | P | 1,000 | $30.28 | A | 11,000 | D | |
| Common StockF1 | Aug 17, 2015 | P | 1,000 | $20.00 | A | 1,000 | I | By step-daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.